ATLASATLAS fair value
ATLAS has no fair value for this stock today.
BrightGene Bio Medical Technology C (688166.SHG)
BrightGene Bio Medical Technology C stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Shanghai Stock Exchange · China
CN¥29.88▼ -5.65%
Prices as of Oct 27, 2026 · CNY
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on BrightGene Bio Medical Technology C in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On BrightGene Bio Medical Technology C
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives BrightGene Bio Medical Technology C a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥26.82 and CN¥32.75; in 9 out of 10, between CN¥22.48 and CN¥39.08. Estimated annual volatility is 56%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CN¥13.4B
- Market cap (USD)
- $2.0B
- P/E ratio
- 139.8
- Dividend yield
- 0.05%
- 52-week high
- CN¥72.88
- 52-week low
- CN¥28.74
- Revenue (12 months)
- CN¥1.4B
- Gross margin
- 52.8%
- Operating margin
- 21.1%
- Net margin
- 7.1%
- Beta
- 0.19
What this means
ATLAS does not publish a fair value for 688166.SHG right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 688166.SHG has traded between CN¥28.74 and CN¥72.88. Today it is 59.0% below that high and 4% above its low.
On the business: net margin is 7.1%; it trades at 139.8 times earnings.
Its beta is 0.19: it tends to move less than the market.
About the company
BrightGene Bio-Medical Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China and internationally.
Want to see everything about BrightGene Bio Medical Technology C?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does BrightGene Bio Medical Technology C do?
BrightGene Bio-Medical Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China and internationally.
What is the chance 688166.SHG goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, 688166.SHG ends the month between CN¥26.82 and CN¥32.75.
How big is BrightGene Bio Medical Technology C and what is its P/E ratio?
BrightGene Bio Medical Technology C's market capitalization is CN¥13.4B. Its price-to-earnings (P/E) ratio is 139.8: you pay CN¥139.8 for each CN¥1.00 of yearly earnings.
Does BrightGene Bio Medical Technology C pay a dividend?
Yes. 688166.SHG's current dividend yield is 0.05% at today's price (CN¥29.88).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer